FIELD: medicine, physiology.
SUBSTANCE: invention relates to the development of agent as a protective solution used for preserving leukocytes at negative temperatures and their retaining in physiologically active state after escape from cold hypobiosis. The solution (pH 7.0-7.4) contains glycerol, hydroxymethylpyrimidine succinate and modegel taken in the optimal ratio. The protective solution provides safety of high percent of functionally active leukocyte cells.
EFFECT: valuable properties of solution.
3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
CRYOCONSERVING AGENT FOR LEUCOCYTES | 2006 |
|
RU2301524C1 |
CRYOPROTECTIVE SOLUTION FOR MODERATELY HYPOTHERMIC LEUKOCYTE PRESERVATION (-40°C) | 2009 |
|
RU2439877C2 |
SOLUTION FOR LEUKOCYTE PRESERVATION AT NEAR-ZERO TEMPERATURE | 2006 |
|
RU2311027C1 |
COLD-SAFETY SOLUTION FOR FREEZING LEUKOCYTES AT SUB-MODERATE TEMPERATURE | 2002 |
|
RU2240000C2 |
FROST PROTECTION SOLUTION FOR NUCLEAR BLOOD CELL FREEZING | 2011 |
|
RU2464991C1 |
CRYOPROTECTIVE SOLUTION FOR LEUKOCYTE FREEZING AT LOW TEMPERATURE | 2004 |
|
RU2290808C2 |
SOLUTION FOR CELL SUSPENSIONS PRESERVATION | 2015 |
|
RU2621295C2 |
CRYOPROTECTIVE SOLUTION TO FREEZE LEUCOCYTES AT MODERATE-LOW TEMPERATURE | 2001 |
|
RU2184449C1 |
WHOLE BLOOD CRYOPROTECTANT | 2023 |
|
RU2816446C1 |
CRYOPRESERVING AGENT FOR BLOOD NUCLEOCYTE FREEZING | 2013 |
|
RU2530149C1 |
Authors
Dates
2005-10-10—Published
2004-01-19—Filed